Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1275 results for "ranbaxy"

Sun Pharma chief expects Ranbaxy deal to be closed by mid-Feb
Business Standard

Sun Pharma chief Dilip S Shanghvi expects Ranbaxy deal to be c...

HYDERABAD: Drug major Sun Pharma's top executive Dilip S Shanghvi expects the USD 4-billion Ranbaxy deal to be concluded by middle of next month while stating that the key challenge before the combined entity would be to rebuild the confidence of ... Economic Times, 2 hours ago
Business Standard

Sun Pharma, Ranbaxy integration to be over by Feb-end: Dilip Shanghvi

Sun Pharmaceuticals Ltd is likely to complete the integration of Ranbaxy by end of next month if all regulatory approvals come as expected, according to its founder - Managing Director, Dilip S Shanghvi. Speaking to newspersons on the sidelines of ...
 Hindu Business Line4 hours ago Sun Pharma: Gujarat HC sanctions Ranbaxy merger  India Infoline2 months ago Sun Pharma, Ranbaxy Laboratories hit new high  Business Standard2 months ago Sun Pharma, Ranbaxy slip in early trade  India Infoline2 months ago

Six in Sixty: Stocks you should keep on your radar

CNBC-TV18's Ekta Batra lists out stocks that you should focus on – Suzlon, Sun Pharma, Ranbaxy, HUL, ITC, Zee Entertainment, Cairn India, Tata Motors
 Money Control3 days ago Here are top 10 stocks to focus on December 9  Money Control1 month ago Here are top 10 stocks to keep an eye on November 20  Money Control2 months ago Top 10 stocks to keep an eye on October 29  Money Control2 months ago

Ranbaxy Laboratories allots shares under ESOP

Ranbaxy Laboratories said that the company has allotted 6,40,597 equity shares on exercise of stock options under the Employees Stock Option Scheme of the company. The paid-up equity share capital of the company post allotment is 425,663,497 ...
 MyIris2 days ago Ranbaxy Laboratories allots equity shares  HDFC Securities2 days ago Ranbaxy Laboratories allots equtiy shares  Business Standard1 month ago

Buy Lupin 1500 call, Ranbaxy 700 Call: VK Sharma

VK Sharma of HDFC Securities recommends buying Lupin 1500 call and Ranbaxy Labs 700 Call.
 Money Control2 days ago
Business Standard India

Why BioLight Life Sciences' India entry is good news for Dilip Shanghvi

After a dream run with the Ranbaxy acquisition, Sun Pharma founder Dilip Shanghvi's fortune seems to be on an uptrend. Israel-based BioLight Life Sciences, in which Shanghvi holds a 21.45 per cent stake, is gearing up for its India foray in the next ...
 Business Standard India5 days ago Eight best acquisitions from last year  Economic Times3 weeks ago
Business Standard

First infliximab similar biologic launched in India

India-based Ranbaxy Laboratories (Ranbaxy) announced on 1 December 2014 that it had launched its infliximab similar biologic, BOW015 in India. This is the first infliximab similar biologic to be launched
 GaBi Online2 weeks ago Ranbaxy announces launch of anti-malarial drug in African countries  Individual.com3 weeks ago Ranbaxy receives approval for malaria drug Synriam from 7 African countries  Business Standard1 month ago Ranbaxy Laboratories : Labs to take its novel drug Synriam to Africa  4 Traders1 month ago
Business Standard

Columns: CCI's Sun-Ranbaxy master stroke

Sun Pharmaceutical's $4 billion acquisition of rival drug company, Ranbaxy Laboratories, recently became the first transaction to be conditionally approved by the Competition Commission of India (CCI), after a detailed Phase II inquiry. CCI's ...
 Financial Express1 month ago CCI rider likely to have insignificant impact on Sun Pharma-Ranbaxy  Business Standard1 month ago Sun Pharma, Ranbaxy climb after CCI clears merger deal  Myiris1 month ago Sun, Ranbaxy to Divest Seven Drugs to Get CCI Final Nod  PharmaAsia1 month ago
Business Standard


The Competition Commission of India (CCI) last week approved the merger of Ranbaxy Laboratories with Sun Pharma on the condition that 7 overlapping products of the two companies should be sold out in six months to avoid a monopoly situation in the ...
 PharmaBiz1 month ago Divestment of 7 products may not impact working of Sun-Ranbaxy merger  PharmaBiz1 month ago Pharmaceutical Newsletter - December 08 to 12, 2014  India Infoline1 month ago India,United States : CCI grants approval for SUN PHARMA and RANBAXY LABS merger [TendersInfo (India)]  Pharmacy Choice1 month ago

Stocks in news: TCS, OIL, Financial Tech, Siemens, HDFC

TCS | ING Vysya Bank | Oil India | ONGC | Coal India | GMR Infrastructure | Colgate | Ranbaxy Labs | Biocon | Financial Technologies | Sesa Sterlite | Siemens | HDFC and Jindal Stainless are stocks, which are in the news today.
 Money Control1 month ago Stocks in news: Sun Pharma, Ranbaxy, ITC, Cadila, OnMobile  Money Control1 month ago Stocks in news: Tata Motors, Infosys, IRB Infra, Sun Pharma  Money Control1 month ago Stocks in news: Sun Pharma, Hero, Tata Power, PVR, SREI  Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less